BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang MC, Chang YT, Su TC, Yang WS, Chen CL, Tien YW, Liang PC, Wei SC, Wong JM. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis. Pancreas 2007;35:16-21. [PMID: 17575540 DOI: 10.1097/MPA.0b013e3180547709] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Mandili G, Follia L, Ferrero G, Katayama H, Hong W, Momin AA, Capello M, Giordano D, Spadi R, Satolli MA, Evangelista A, Hanash SM, Cordero F, Novelli F. Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. Cancers (Basel) 2020;12:E746. [PMID: 32245227 DOI: 10.3390/cancers12030746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Bao B, Wang Z, Li Y, Kong D, Ali S, Banerjee S, Ahmad A, Sarkar FH. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta. 2011;1815:135-146. [PMID: 21129444 DOI: 10.1016/j.bbcan.2010.11.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 47] [Article Influence: 1.8] [Reference Citation Analysis]
3 Dalbec KM, Max Schmidt C, Wade TE, Wang S, Swartz-Basile DA, Pitt HA, Zyromski NJ. Adipokines and cytokines in human pancreatic juice: unraveling the local pancreatic inflammatory milieu. Dig Dis Sci 2010;55:2108-12. [PMID: 19757043 DOI: 10.1007/s10620-009-0977-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 White DL, Hoogeveen RC, Chen L, Richardson P, Ravishankar M, Shah P, Tinker L, Rohan T, Whitsel EA, El-Serag HB, Jiao L. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 2018;7:2180-91. [PMID: 29573228 DOI: 10.1002/cam4.1426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
5 Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, Rifai N, Pollak MN, Cochrane BB, Kaklamani V, Lin JH, Manson JE, Fuchs CS, Wolpin BM. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013;105:95-103. [PMID: 23243202 DOI: 10.1093/jnci/djs474] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 7.6] [Reference Citation Analysis]
6 Stolzenberg-Solomon RZ, Weinstein S, Pollak M, Tao Y, Taylor PR, Virtamo J, Albanes D. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol. 2008;168:1047-1055. [PMID: 18801887 DOI: 10.1093/aje/kwn221] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
7 Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015;21:4323-33. [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
8 Hao M, Li W, Yi L, Yu S, Fan G, Lu T, Yang X, Wang G, Zhang D, Ding J, Zhang K, Zhang R, Lin G, Han Y, Wang L, Li J. Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer. Sci Rep 2016;6:27415. [PMID: 27271825 DOI: 10.1038/srep27415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
9 Polvani S, Tarocchi M, Tempesti S, Bencini L, Galli A. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World J Gastroenterol. 2016;22:2441-2459. [PMID: 26937133 DOI: 10.3748/wjg.v22.i8.2441] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
10 Gasiorowska A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E. Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer. Dig Dis Sci 2016;61:1121-9. [PMID: 26597191 DOI: 10.1007/s10620-015-3972-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xu Y, Qin T, Li J, Wang X, Gao C, Xu C, Hao J, Liu J, Gao S, Ren H. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer. Int J Mol Sci. 2017;18:622. [PMID: 28333072 DOI: 10.3390/ijms18040622] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
12 Wei T, Ye P, Peng X, Wu LL, Yu GY. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies. Oncotarget 2016;7:48671-91. [PMID: 27119501 DOI: 10.18632/oncotarget.8932] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
13 Yamada T, Araki H, Watabe K, Kamada Y, Kiso S, Ogiyama H, Nishihara T, Kihara S, Funahashi T, Shimomura I, Tsutsui S, Hayashi N. Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice. J Gastroenterol 2010;45:742-9. [PMID: 20155376 DOI: 10.1007/s00535-010-0205-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
14 Katira A, Tan PH. Evolving role of adiponectin in cancer-controversies and update. Cancer Biol Med 2016;13:101-19. [PMID: 27144066 DOI: 10.28092/j.issn.2095-3941.2015.0092] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
15 Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, Karmaniolas K, Pelecanos N, Tseleni-Balafouta S, Dionyssiou-Asteriou A. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control. 2009;20:625-633. [PMID: 19051043 DOI: 10.1007/s10552-008-9273-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
16 Phelip JM, Bageacu S, Baconnier M, Barabino G, Del Tedesco E, Benhamou PY, Roblin X. Comparison of adiponectin concentration between pancreatic cancer and colorectal cancer. J Gastrointest Oncol 2011;2:232-9. [PMID: 22811857 DOI: 10.3978/j.issn.2078-6891.2011.031] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Izadi V, Farabad E, Azadbakht L. Serum adiponectin level and different kinds of cancer: a review of recent evidence. ISRN Oncol. 2012;2012:982769. [PMID: 23213569 DOI: 10.5402/2012/982769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
18 Álvarez-Artime A, García-Soler B, Sainz RM, Mayo JC. Emerging Roles for Browning of White Adipose Tissue in Prostate Cancer Malignant Behaviour. Int J Mol Sci 2021;22:5560. [PMID: 34074045 DOI: 10.3390/ijms22115560] [Reference Citation Analysis]
19 Akimoto M, Maruyama R, Kawabata Y, Tajima Y, Takenaga K. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis. Cell Death Dis. 2018;9:804. [PMID: 30038429 DOI: 10.1038/s41419-018-0851-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
20 Cai O, Tan S. From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis. Gastroenterol Res Pract 2017;2017:3246459. [PMID: 28197205 DOI: 10.1155/2017/3246459] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
21 Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547-594. [PMID: 22547160 DOI: 10.1210/er.2011-1015] [Cited by in Crossref: 363] [Cited by in F6Publishing: 305] [Article Influence: 40.3] [Reference Citation Analysis]
22 Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomark 2011-2012;11:1-14. [PMID: 22820136 DOI: 10.3233/CBM-2012-0260] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Guo Q, Kang M, Zhang B, Chen Y, Dong X, Wu Y. Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. J Cancer Res Clin Oncol. 2010;136:1627-1631. [PMID: 20174821 DOI: 10.1007/s00432-010-0820-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
24 Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146:357-373. [PMID: 24315827 DOI: 10.1053/j.gastro.2013.11.051] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 13.8] [Reference Citation Analysis]
25 Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog. 2012;51:53-63. [PMID: 22162231 DOI: 10.1002/mc.20778] [Cited by in Crossref: 119] [Cited by in F6Publishing: 102] [Article Influence: 13.2] [Reference Citation Analysis]
26 Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013;13:340-351. [PMID: 23331006 DOI: 10.2174/1566524011313030003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 90] [Article Influence: 2.4] [Reference Citation Analysis]